A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators Source: Eur Respir Rev, 27 (148) 170124; 10.1183/16000617.0124-2017 Year: 2018
ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020 Year: 2020
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020
Targeting the arginase pathway: potential developments as new avenues for treatment Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
CF clinical care and its delivery: current and future challenges Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission Year: 2019
Out of centre sleep testing: challenges and advances Source: Sleep and Breathing Conference 2021 Year: 2021
COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007
Introduction: CPET in clinical practice. Recent advances, current challenges and future directions Source: Eur Respir Monogr 2018; 80: x-xxv Year: 2018
Clinical asthma phenotypes in the real world: opportunities and challenges Source: Breathe 2015; 11:186-193 Year: 2015
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021 Year: 2021
The microbiome in respiratory medicine: current challenges and future perspectives Source: Eur Respir J , 49 (4) 1602086; DOI: 10.1183/13993003.02086-2016 Year: 2017
Developmental control of CFTR: from bioinformatics to novel therapeutic approaches Source: Eur Respir J 2015; 45: 18-20 Year: 2015
Challenges, impact and the future Source: Eur Respir Monogr 2019; 83: 240-244 Year: 2019
Bringing it all together: common pathways, emerging therapeutics and future directions Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities Source: Eur Respir J 2014; 44: 513-522 Year: 2014
Lung function testing in the COVID era: safety concerns you should consider Source: COVID-19 Videos Year: 2020
The challenges of coupling new diagnostics and treatment capacity at country level Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013